COVID19 Clinical Trials

5 recruiting

Frequently Asked Questions

Common questions about COVID19 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection

COVID19
Consorci Sanitari de Terrassa3,000 enrolled1 locationNCT04367883
Recruiting
Early Phase 1

Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues

ObesityMultiple SclerosisLong COVID+4 more
University of Chicago30 enrolled1 locationNCT06171152
Recruiting
Phase 1

Covid-19 and Influenza Oral Vaccine Study

Influenza, Humancovid19 Infection
Vaxine Pty Ltd100 enrolled1 locationNCT06355232
Recruiting
Not Applicable

Long-Covid-19 Alleviation Through Learning Mindfulness Study

Post-Acute COVID-19 SyndromeLong COVIDLong Covid19+3 more
Columbia University400 enrolled1 locationNCT07140094
Recruiting
Phase 1Phase 2

Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)

Covid19 Virus Infection
All Natural Medicine Clinic, LLC100 enrolled1 locationNCT04790240
Recruiting
Not Applicable

Acupuncture for Post COVID-19 Condition (Long COVID) Neuropsychiatric Symptoms

Long Covid19AcupunctureNeuropsychiatric Symptom
Hong Kong Baptist University160 enrolled1 locationNCT06633666
Recruiting
Not Applicable

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Long Covid19Neuropsychiatric SymptomsElectro-acupuncture
Hong Kong Baptist University150 enrolled1 locationNCT05890508
Recruiting

Clinical Characteristics and Long Term Impact on Pediatric COVID-19 in Taiwan

Long Covid19
National Taiwan University Hospital3,000 enrolled1 locationNCT05582512
Recruiting

Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Long COVIDPost-Acute COVID-19Post-Acute COVID19 Syndrome
Central Hospital, Nancy, France500 enrolled1 locationNCT05610436
Recruiting

COVID-19 Vaccines Safety Tracking (CoVaST)

Adverse Reaction to VaccineCOVID19 Vaccine
Masaryk University30,000 enrolled14 locationsNCT04834869
Recruiting
Phase 1

Safety and efficacy of intranasal delivery of BromAc® (Bromelain & Acetylcysteine) in swab positive SARS-CoV-2 COVID-19 patients

COVID19
Mucpharm Pty Ltd40 enrolled1 locationACTRN12620000788976
Recruiting
Phase 3

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

COVID19CoronavirusCoronavirus Infection+2 more
West Virginia University240 enrolled1 locationNCT04376034